e-learning
resources
Munich 2014
Saturday, 06.09.2014
PG13 Assessment of the obstructive sleep apnoea patient
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiovascular assessment
J.L. Pepin (Grenoble, France)
Source:
International Congress 2014 – PG13 Assessment of the obstructive sleep apnoea patient
Session:
PG13 Assessment of the obstructive sleep apnoea patient
Session type:
Postgraduate Course
Number:
137
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J.L. Pepin (Grenoble, France). Cardiovascular assessment. International Congress 2014 – PG13 Assessment of the obstructive sleep apnoea patient
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Cardiovascular patients
Source: Eur Respir Monogr 2021; 90: 208-228
Year: 2021
Cardiovascular diseases and COVID-19
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021
Lung function decline and outcomes in an elderly population: findings from the Cardiovascular Health Study
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005
Cardiovascular risk detection in COPD
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Risk Factors Associated to Cardiovascular Events after Bronchiectasis Exacerbation: A Prospective Study.
Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy
Year: 2020
Metabolic assessment
Source: International Congress 2014 – PG13 Assessment of the obstructive sleep apnoea patient
Year: 2014
LATE-BREAKING ABSTRACT: Daytime motor activity and emphysema on CT: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung and Sleep Studies
Source: International Congress 2014 – Mechanisms of exercise limitation in disease
Year: 2014
Cardiovascular morbidity in OSA
Source: Annual Congress 2003 - PG4 - Obstructive sleep apnoea - current pathophysiological, clinical and therapeutic concepts
Year: 2003
Exercise in Cardiac Diseases
Source: School Course 2013 - Clinical exercise testing
Year: 2013
Cardiovascular monitoring during resuscitation: between physiology and pragmatism
Source: International Congress 2015 – PG3 Cardiorespiratory monitoring in critically ill patients
Year: 2015
Main and additional predictors of COPD progression
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
The Relation Between Cardiovascular Diseases And Antropometric Measurements In Patients With Obstructive Sleep Apnea: A Single Center Study
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018
Cardiovascular disease in COPD
Source: Eur Respir Monogr 2020; 88: 47-65
Year: 2020
Cardiovascular comorbidity in COPD: Tip of iceberg
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Nutritional assessment and therapy in COPD: a European Respiratory Society statement
Source: Eur Respir J 2014; 44: 1504-1520
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept